文献速递瓣膜病与结构性心脏病

大规模蛋白质组学识别主动脉瓣狭窄的新生物标志物和循环风险因素

Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

在CHS中验证6种蛋白与中重度AS相关,其中MMP12与瓣膜钙化进展相关,C1QTNF1经孟德尔随机化提示潜在因果效应。

要点

  • MMP12是与AS风险相关的潜在新型循环生物标志物。
  • C1QTNF1可能是预防AS进展的新靶点。
  • 多种血浆蛋白与主动脉瓣峰值流速及AS住院风险相关。

核心结论

  • MMP12是AS风险的潜在新型循环生物标志物。
  • C1QTNF1是预防AS进展的潜在新靶点。

研究设计与样本

  • 在ARIC研究中,于中年(V3,n=11,430,年龄60±6岁)和晚年(V5,n=4,899,年龄76±5岁)测量4,877种血浆蛋白(SomaScan适配体亲和力检测)。
  • 采用多变量线性回归和Cox比例风险回归,分析蛋白与V5时超声心动图主动脉瓣峰值流速及无量纲指数的横断面关联,以及与V3后AS相关住院的关联。
  • 在独立样本中重复分析,并进行孟德尔随机化分析和人主动脉瓣组织基因表达评估。

主要发现

  • 在心血管健康研究(CHS)的3,413名参与者中,6种蛋白与 adjudicated 中重度AS显著相关,包括MMP12、C1QTNF1和生长分化因子-15。
  • MMP12还与6年内主动脉瓣峰值流速增加更大、主动脉瓣钙化程度更高相关,且在钙化瓣膜组织中表达高于正常或纤维化组织。
  • 孟德尔随机化分析显示C1QTNF1对AS和主动脉瓣峰值流速均具有一致的潜在因果效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist regarding risk factors for aortic stenosis (AS). The plasma proteome is a promising phenotype for discovery of novel biomarkers and potentially causative mechanisms. OBJECTIVES: The aim of this study was to discover novel biomarkers with potentially causal associations with AS. METHODS: We measured 4,877 plasma proteins (SomaScan aptamer-affinity assay) among ARIC (Atherosclerosis Risk In Communities) study participants in mid-life (visit 3 [V3]; n = 11,430; age 60 ± 6 years) and in late-life (V5; n = 4,899; age 76 ± 5 years). We identified proteins cross-sectionally associated with aortic valve (AV) peak velocity (AVmax) and dimensionless index by echocardiography at V5 and with incident AV-related hospitalization after V3 with the use of multivariable linear and Cox proportional hazard regression. We assessed associations of candidate proteins with changes in AVmax over 6 years and with AV calcification with the use of cardiac computed tomography, replicated analysis in an independent sample, performed Mendelian randomization, and evaluated gene expression in explanted human AV tissue. RESULTS: Fifty-two proteins cross-sectionally were associated with AVmax and dimensionless index at V5 and with risk of incident AV-related hospitalization after V3. Among 3,413 participants in the Cardiovascular Health Study, 6 of those proteins were significantly associated with adjudicated moderate or severe AS, including matrix metalloproteinase 12 (MMP12), complement C1q tumor necrosis factor-related protein 1 (C1QTNF1), and growth differentiation factor-15. MMP12 was also associated with greater increase in AVmax over 6 years, greater degree of AV calcification, and greater expression in calcific compared with normal or fibrotic AV tissue. C1QTNF1 had consistent potential causal effects on both AS and AVmax according to Mendelian randomization analysis. CONCLUSIONS: These findings identify MMP12 as a potential novel circulating biomarker of AS risk and C1QTNF1 as a new putative target to prevent AS progression.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Shelbaya K, Arthur V, Yang Y, et al. Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. 2024. PMID: 38296402. doi:10.1016/j.jacc.2023.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。